Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab

Gut. 2008 Apr;57(4):559; author reply 559-60.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Crohn Disease / drug therapy*
  • Female
  • Gastrointestinal Agents / adverse effects*
  • Humans
  • Lupus Erythematosus, Systemic / chemically induced*
  • Middle Aged
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab